These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38458206)
41. Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation. Mansfield M; McLaughlin AM; Roycroft E; Montgomery L; Keane J; Fitzgibbon MM; Rogers TR Microbiol Spectr; 2022 Jun; 10(3):e0234521. PubMed ID: 35471095 [TBL] [Abstract][Full Text] [Related]
42. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting. Opota O; Zakham F; Mazza-Stalder J; Nicod L; Greub G; Jaton K J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30541937 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of the molecular bacterial load assay for detecting viable Mycobacterium tuberculosis in cerebrospinal fluid before and during tuberculous meningitis treatment. Hai HT; Sabiiti W; Thu DDA; Phu NH; Gillespie SH; Thwaites GE; Thuong NTT Tuberculosis (Edinb); 2021 May; 128():102084. PubMed ID: 33965677 [TBL] [Abstract][Full Text] [Related]
44. Comparison of Xpert MTB/RIF Ultra with Xpert MTB/RIF for the detection of Mycobacterium tuberculosis and rifampicin resistance in a primary-level clinic in rural China. Li M; Qiu Y; Guo M; Qu R; Tian F; Wang G; Wang Y; Ma J; Liu S; Takiff H; Tang YW; Gao Q Tuberculosis (Edinb); 2023 Sep; 142():102397. PubMed ID: 37597313 [TBL] [Abstract][Full Text] [Related]
45. The new Xpert Mycobacterium tuberculosis/rifampicin (MTB/Rif) Ultra assay in comparison to Xpert MTB/Rif assay for diagnosis of tuberculosis in children and adolescents. Kaur H; Guglani V; Singhal L; Randev S; Kumar P; Gupta V J Trop Pediatr; 2023 Dec; 70(1):. PubMed ID: 38116810 [TBL] [Abstract][Full Text] [Related]
46. Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation. Ghebrekristos YT; Beylis N; Centner CM; Venter R; Derendinger B; Tshivhula H; Naidoo S; Alberts R; Prins B; Tokota A; Dolby T; Marx F; Omar SV; Warren R; Theron G Lancet Microbe; 2023 Oct; 4(10):e822-e829. PubMed ID: 37739001 [TBL] [Abstract][Full Text] [Related]
47. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration. Tadesse M; Aragaw D; Rigouts L; Abebe G Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234 [TBL] [Abstract][Full Text] [Related]
48. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal. Khadka P; Thapaliya J; Basnet RB; Ghimire GR; Amatya J; Rijal BP BMC Infect Dis; 2019 Dec; 19(1):1090. PubMed ID: 31888522 [TBL] [Abstract][Full Text] [Related]
49. The value of Xpert MTB/RIF assay of urine samples in the early diagnosis of smear-negative urinary tuberculosis. Wang Y; Tan J; Lei L; Yuan Y; Li W; Zhao Y; Wang Y; Niu X; Li Z; Wei L; Han Y; Cheng M; Guo X; Han X; Wang W Eur J Med Res; 2022 Dec; 27(1):300. PubMed ID: 36539899 [TBL] [Abstract][Full Text] [Related]
50. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting]. Ozkutuk N; Surucüoglu S Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. Sekadde MP; Wobudeya E; Joloba ML; Ssengooba W; Kisembo H; Bakeera-Kitaka S; Musoke P BMC Infect Dis; 2013 Mar; 13():133. PubMed ID: 23497044 [TBL] [Abstract][Full Text] [Related]
53. Diagnostic accuracy of the new Xpert MTB/RIF Ultra for tuberculosis disease: A preliminary systematic review and meta-analysis. Zhang M; Xue M; He JQ Int J Infect Dis; 2020 Jan; 90():35-45. PubMed ID: 31546008 [TBL] [Abstract][Full Text] [Related]
54. Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes. Pires MM; Pereira GR; Barbosa MS; Dias NJD; Secchi C; Hoff JS; Silva DR Lung; 2020 Dec; 198(6):985-989. PubMed ID: 33128653 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia. Mavenyengwa RT; Shaduka E; Maposa I Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955 [TBL] [Abstract][Full Text] [Related]
56. Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda. Kakinda M; Tugumisirize D; Nyombi A; Mugisha M; Turyahabwe S; Walusimbi S; Matovu JKB PLoS One; 2022; 17(10):e0275960. PubMed ID: 36215286 [TBL] [Abstract][Full Text] [Related]
57. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation. Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea. Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246 [TBL] [Abstract][Full Text] [Related]
60. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts. Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]